Upcoming Discipline Hearings

The schedule is subject to change.

All hearings are open to the public and unless otherwise stated are held in Council Chambers at the Ontario College of Pharmacists’ Office at 483 Huron Street in Toronto, Ontario.

Hearings commence at 9:30a.m.

If you plan to attend, or for further information, please e-mail hearingsoffice@ocpinfo.com or phone 1-416-962-4861.

The College is committed to supporting accessibility and will provide accessible formats and communication supports for persons with disabilities. If you would like to attend a discipline hearing and require accommodations, please contact us at accessibility@ocpinfo.com to make appropriate arrangements.

Please note: The College is a SCENT FREE environment. Scented products may trigger reactions such as respiratory distress and headaches. In consideration of others, people attending the College are asked to refrain from wearing scented products. Your co-operation is appreciated.

Hearing Dates: September 24, 2019,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Di Pierdomenico committed professional misconduct in that he

  • Was found guilty, on or about March 21, 2018, of criminal mischief over $5,000, which is an offence contrary to section 430(3) of the Criminal Code of Canada;
  • Engaged in mischief, on or about November 30, 2015, by damaging and vandalizing property, including electrical wiring, plumbing and household property, the value of which exceeded $5,000.

In particular, it is alleged that he

  • Was found guilty of an offence that is relevant to his suitability to practice;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: September 26, 2019,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Shier committed professional misconduct in that

  • He failed to report to the College in a timely manner that on or about February 25, 2016 he was charged with counselling an indictable offence which was not committed, contrary to section 464(a) of the Criminal Code, and conspiracy to commit murder, contrary to section 465(1)(a) of the Criminal Code;
  • On or about March 9, 2017, in written and/or electronic material he submitted to the College during the renewal of his certificate of registration he indicated that he was not the subject of a criminal proceedings, at a time he was charged with offences under the Criminal Code;
  • He was found guilty of counselling an indictable offence which was not committed, contrary to section 464(a) of the Criminal Code.

In particular, it is alleged that he

  • Breached a term, condition or limitation imposed on his certificate of registration, as set out in section 5 paragraph 1(ii) of Ontario Regulations 202/94;
  • Signed or issued, in his professional capacity, a document he knew contained a false or misleading statement;
  • Was found guilty of an offence that is relevant to his suitability to practice;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: October 1, 2019, October 2, 2019,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hopkins, as a pharmacist in Part B of the register, committed professional misconduct in that he

  • Failed to complete by February 13, 2018 the specified continuing education or remediation program ordered by a panel of the Inquiries, Complaints and Reports Committee on or about February 13, 2017

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to comply with an order of a Committee or a panel of a Committee of the College
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: October 7, 2019, October 8, 2019, October 9, 2019, October 10, 2019,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Czilli, on one or more occasions during the period July 3, 2015 to April 1, 2017, while engaged in the practice of pharmacy as owner, Designated Manager and/or dispensing pharmacist at Wellington Apothecary in Windsor, Ontario, committed professional misconduct in that she

  • Submitted accounts or charges for services that she knew or reasonably ought to have known were false or misleading to the Ontario Drug Benefit program for MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
  • Falsified pharmacy records in relation to claims made to theOntario Drug Benefit Program for MedsCheck reviews that were never conducted and/or were non-compliant with the guidelines of the Ministry of Health and Long Term Care; and/or,
  • Failed to keep records as required in relation to MedsCheck claims made to the Ontario Drug Benefit Program.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Falsified records relatingto her practice
  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement
  • Submitted an account or charge for services that she knew was false or misleading statement
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular sections 20 and 21 of Ontario Regulation 264/16
  • Failed to keep records as required
  • Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: November 1, 2019,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Newman, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner of the Delaware Pharmacy in London, committed professional misconduct in or about the period from August 1, 2017 to December 31, 2017, in that

  • He dispensed naloxone kits or caused naloxone kits to be dispensed to patients without regard to individual need and/or clinical appropriateness;
  • He solicited or permitted the solicitation of patients without complying with the disclosure requirements set out in paragraph 11 of section 2(1) of Ontario Regulation 130/17, as amended;
  • He or his employees or agents misleadingly claimed to be representatives of a government program when soliciting patients to whom to distribute naloxone kits;
  • He improperly directed or permitted non-pharmacist employees or agents to dispense naloxone kits to patients in the community.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to provide an appropriate level of supervision to a person or persons whom he was professionally obligated to supervise: namely, employees or agents of the Delaware Pharmacy dispensing naloxone kits in the community
  • Solicited or permitted the solicitation of a person or persons to receive naloxone kits without first advising each individual at the earliest possible time during the communication that the purpose of the communication was to solicit use of his professional services and that the person may elect to have him end the solicitation immediately or at any time during the solicitation if he or she wishes to do so, and without ensuring that the solicitation ended immediately if the person so elected
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: November 1, 2019,

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Newman, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner of the Delaware Pharmacy in London, Ontario, in or about the period from August 1, 2017 to July 31, 2018, committed professional misconduct in that

  • He dispensed naloxone kits or caused naloxone kits to be dispensed to patients without regard to individual need and/or clinical appropriateness;
  • He solicited or permitted the solicitation of patients without complying with the disclosure requirements set out in paragraph 11 of section 2(1) of Ontario Regulation 130/17, as amended;
  • He or his employees or agents misleadingly claimed to be representatives of a government program when soliciting patients to whom to distribute naloxone kits;
  • He improperly directed or permitted non-pharmacist employees or agents to dispense naloxone kits to patients in the community;
  • He failed to carry out or abide by an undertaking given to the College on February 21, 2018 in which he undertook to immediately cease the dispensing and/or sale of naloxone or facilitating the dispensing and/or sale of naloxone to persons except in accordance with the College”™s guidance document, “Dispensing or Selling Naloxone,” and to ensure that appropriate assessment and training are provided by a pharmacist to persons dispensed and/or sold naloxone.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Failed to provide an appropriate level of supervision to a person or persons whom he was professionally obligated to supervise: namely, employees or agents of the Delaware Pharmacy dispensing naloxone kits in the community;
  • Solicited or permitted the solicitation of a person or persons to receive naloxone kits without first advising each individual at the earliest possible time during the communication that the purpose of the communication was to solicit use of his professional services and that the person may elect to have him end the solicitation immediately or at any time during the solicitation if he or she wishes to do so, and without ensuring that the solicitation ended immediately if the person so elected;
  • Failed to carry out or abide by an undertaking given to the College;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: November 11, 2019, November 12, 2019,

Summary of Allegations

As a result of referrals by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Aslam, while he was a pharmacist and Designated Manager, committed professional misconduct in that

  • Between December 2014 and July 2015, he engaged in touching of a sexual nature towards [Name], an employee of the Pharmacy who was also a patient at the relevant time, including by:
    • In or around May 2015, attempting to touch her breasts and forcing his hands on her;
  • Between December 2014 and July 2015, he engaged in behaviour and/or remarks of a sexual nature towards [Name], an employee of the Pharmacy, who was also a patient at the relevant time, including by:
    • In or around February 2015, requesting that she hug him and attempting to touch her
  • Between April 2013 and July 2015, he harassed and/or sexually harassed [Name], an employee of the Pharmacy, who was also a patient for at least a portion of this time, including by;
    • On or about September 14, 2013, in his office in the Pharmacy:
      1. Attempting, repeatedly, to reach in to her shirt and her pants;
      2. Placing her hand on his groin area;
    • In or around the summer of 2014, in his office in the Pharmacy, placing his hand on her breasts;
    • In or around May 2015, attempting to touch her breasts and forcing his hands on her;
    • In or around February 2015, requesting that she hug him and attempting to touch her; and
    • Engaging in other unwelcome touching and advances from time to time
  • He failed to provide to the Registrar the details of charges against him under the Criminal Code of Canada, as set out in an information sworn on or about August 13, 2015, namely charges relating to the offence of sexual assault, within 30 days of those charges having arisen, as required by the By-Laws of the Ontario College of Pharmacists.

In particular, it is alleged that he

  • sexually abused a patient
  • contravened a term, condition or limitation imposed on his certificate of registration
  • failed to maintain the standards of the profession
  • engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional

The hearing in this matter commenced on November 5 and 6, 2018. Further hearing dates will be scheduled.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe committed professional misconduct in that she:

  • Failed to fulfill all requirements related to working with a practice mentor, as ordered by the Discipline Committee on December 8, 2016.

In particular, it is alleged that she

  • Contravened a term, condition or limitation imposed on her certificate of registration;
  • Failed to comply with an order of a panel of a Committee of the College;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Abanzukwe, while practising as a pharmacist, Designated Manager and/or the sole director and shareholder of the corporation that owned and operated Brock Medical Pharmacy at 1637 Dundas Street West in Toronto, Ontario, committed professional misconduct in that she

  • Engaged in the practice of pharmacy while her certificate was suspended from on or around December 1, 2018 to on or around January 31, 2019;
  • Falsified records relating to her practice or a person’s health record with respect to one or more identified prescriptions from on or about December 1, 2018 to on or about January 31, 2019;
  • Kept medications in inventory without expiration dates and/or lot numbers, in or around February of 2019.

In particular, it is alleged that she

  • Contravened a term, condition or limitation imposed on her certificate of registration;
  • Failed to comply with an order of a panel of a Committee of the College;
  • Practised the profession while her certificate was under suspension;
  • Falsified records relating to her practice or a person’s health record;
  • Failed to maintain a standard of practice of the profession;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as unprofessional, dishonourable or disgraceful.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Abdou, as a pharmacist at Martindale IDA Pharmacy in St. Catharines, Ontario, and/or as director of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he

  • Submitted claims to [Insurance Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about March 2017-March 2018

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee that was excessive in relation to the service provided
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Aderinto, as staff pharmacist and Designated Manager of the Erie Health and Wellness Pharmacy (the “Pharmacy”) in Windsor, Ontario, and as sole director and shareholder of the corporation that owns and operates the Pharmacy, committed professional misconduct with respect to the following incidents, in or about July-November 2018, in that he

  • Billed routinely for excessive dispensing fees at weekly intervals for blister pack medications actually dispensed at bi-weekly or monthly intervals, including dispensing fees charged for the medications dispensed to certain identified patients; and/or
  • Created false and/or misleading records routinely indicating blister pack medications were being dispensed at weekly intervals when the medications were actually being dispensed at bi-weekly or monthly intervals, including records for the medications dispensed to certain identified patients.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified a record relating to his practice or a person’s health record
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Contravened the Act, the Drug and Pharmacies Regulations Act, the Regulated Health Professions Act, 1991, the Narcotic Safety and Awareness Act 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, sections 4, 4.1 5, and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or sections 18, 20.2 and/or 27 of O.Reg. 201/96, as amended
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Al-Sakaff, while he was the Designated Manager, as well as a director and shareholder of the owner of Cannon Pharmacy in Hamilton, Ontario (the “Pharmacy”), committed professional misconduct in that:

  • Between November 2015 and February 2017, he employed in the Pharmacy a pharmacist whose certificate of registration had been revoked for cause; and/or
  • On more than one occasion between November 2015 and February 2017:
    • he permitted, consented to or approved, either expressly or by implication, the operation of the Pharmacy without a pharmacist present; and/or
    • he permitted, consented to or approved, either expressly or by implication, the dispensing and/or sale of a drug by an unauthorized person; and/or
    • he signed a hardcopy for a prescription in circumstances where he did not dispense the medication.

In particular, it is alleged that he

  • Failed to maintain the standards of practice of the profession;
  • Falsified a record relating to his practice;
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement;
  • Contravened the Drug and Pharmacies Regulation Act (DRPA), and in particular:
    • s. 143(a) of the DPRA,
    • s. 146(1)(a) of the DPRA, and/or
    • s. 149 of the DPRA;
  • Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Awad, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at John Garland Pharmacy (the “Pharmacy”) in Etobicoke, Ontario, committed professional misconduct in that she

  • Failed to keep records as required respecting her patients and/or practice with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
  • Falsified a record relating to her practice and/or a person”™s health record with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017;
  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017; and/or
  • Submitted an account or charge for services that she knew or ought to have known was false and misleading with respect to one or more of certain identified drugs and/or products from in or about January 2015 to in or about September 2017.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting her patients and/or practice
  • Falsified a record relating to her practice and/or a person”™s health record
  • Signed or issued, in her professional capacity, a document that she knew and/or ought to have known contained a false or misleading statement
  • Submitted an account or charge for services or products that she knew and/or ought to have known was false or misleading
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
    1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40(1) and 54(1) of Ontario Regulation 58/11
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to her suitability to practise, and in particular:
    1. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and sections 40 and 54(1) of Ontario Regulation 58/11
    2. sections 5, 6, and 15(1) of the Ontario Drug Benefit Act and section 27 of Ontario Regulation 201/96
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Aziz, as pharmacist and Designated Manager at The Medicine Shoppe, Toronto, Ontario (the “Pharmacy”), and/or as director of the corporate owner of the Pharmacy, committed professional misconduct in relation to orders processed from Meds Via Canada, in or about 2013-2017, in that he

  • Sold by retail and/or dispensing prescription drugs to patients in the U.S. without a lawful and/or otherwise valid prescription; and/or
  • Contravened the OCP Policy on Prescriptions – Out of Country, dated January-February 2003.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of a profession;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 155 and/or 158 of the Drug and Pharmacies Regulation Act , R.S.O. 1990, c. H-4, as amended;
  • Contravened, while engaged in the practise of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections C.01.041 and/or C.01.042 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Bebawy, as dispensing pharmacist and/or Designated Manager at The Medicine Shoppe in Peterborough, Ontario (the “Pharmacy”), and/or as director and majority shareholder of the corporation that owned and operated the Pharmacy, committed professional misconduct, in or about 2018-2019, in that she

  • Failed to ensure all blister pack prescriptions were checked and/or signed by the pharmacist dispensing the prescriptions to patients, including for certain identified patients;
  • Failed to ensure the prescriptions and/or contents of blister pack prescriptions were recorded accurately for patients, including for certain identified patients;
  • Failed to ensure compliance with the OCP guideline on Multi-Medication Compliance Aids, updated 2013, with respect to billing, dispensing and/or documenting blister pack prescriptions;
  • Billed routinely for excessive dispensing fees at weekly intervals for blister pack prescriptions actually dispensed to patients at bi-weekly or monthly intervals, including for certain identified patients; and/or
  • Creatd false and/or misleading records routinely indicating blister pack prescriptions were being dispensed to patients at weekly intervals when the prescriptions were actually being dispensed to patients at bi-weekly or monthly intervals, including for certain patients.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to provide an appropriate level of supervision to a person whom she was professionally obligated to supervise
  • Failed to keep records as required respecting her patients or practice
  • Falsified a record relating to her practice or a person’s health record
  • Submitted an account or charge for services or products that she knew or ought to have known was false or misleading
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, section 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H. 4; section 20 of O.Reg. 264/16; sections 4, 4.1, 5, and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c. O. 10; and/or sections 18, 20.2 and/or 27 of O.Reg. 201/96, as amended
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Billings committed professional misconduct in that

  • on July 18, 2016 in the Ontario Court of Justice at Lindsay, Ontario, he was found guilty of one count of use of a forged document, contrary to Section 368(1)(a) of the Criminal Code of Canada; and one count of fraud not exceeding $5,000.00, contrary to Section 380(1)(b) of the Criminal Code of Canada;
  • beginning in January 2012 and continuing to February 1, 2016 he self-prescribed medication, by filling out prescriptions for himself and signing the name of his previous family doctor on theprescriptions.

In particular, it is alleged that he

  • was found guilty of offenses that are relevant to his suitability to practice;
  • dispensed or sold drugs for an improper purpose;
  • falsified a record relating to his practice;
  • engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Castillo, while employed as a pharmacist, committed professional misconduct in that she

  • Failed to maintain the professional boundaries of the pharmacist-patient relationship when you developed and engaged in a non-professional, personal relationship with the patient, [Name], from in or about March 2017 toin or about April 2018; and/or
  • Engaged in sexual abuse of the patient, [Name], on one or more occasions, from in or about March 2017 to in or about April 2018.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession;
  • Abused a patient emotionally, verbally or physically;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Fakoori, while engaged in the practice of pharmacy as director, shareholder, owner, designated manager, and/or dispensing pharmacist at Yonge Cummer Pharmacy in North York, Ontario and/or director, shareholder, owner, and/or dispensing pharmacist at Aurora Pharmacy in Aurora, Ontario, committed professional misconduct in that he

  • Failed to keep records as required respecting his patients and/or practice with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017;
  • Falsified a record relating to his practice and/or a person’s health record with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017;
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017; and/or
  • Submitted an account or charge for services that he knew or ought to have known was false and misleading with respect to one or more of certain identified drugs and/or products, from in or about January 2017 to in or about December 2017.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Falsified a record relating to his practice and/or a person’s health record;
  • Signed or issued, in his professional capacity, a document that he knew and/or ought to have known contained a false or misleading statement;
  • Submitted an account or charge for services or products that he knew and/or ought to have known was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular:
    • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act, and
    • sections 18, 19, and 20 of Ontario Regulation 264/16;
  • Contravened a federal, provincial or territorial law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, with respect to the distribution, purchase, sale, dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote the public health, and/or that is otherwise relevant to his suitability to practise, and in particular:
    • sections 155, 163, and 166 of the Drug and Pharmacies Regulation Act, and
    • sections 18, 19, and 20 of Ontario Regulation 264/16;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Forcucci, while he was a pharmacist, committed professional misconduct in that he

i. Sexually abused a patient, [Name], on one or more occasions;

ii. He failed to maintain professional boundaries by developing and pursuing a personal and/or romantic relationship with [Name] who was a patient at the time;

iii. in the alternative to i and ii, he failed to maintain professional boundaries when he developed and pursued a personal and/or romantic relationship with [Name] in circumstances where he was uncertain as to whether [Name] was a patient;

iv. Behaved in an emotionally abusive manner in respect of his personal relationship with [Name], a patient;

v. Provided benzodiazepines to [Name] without a prescription, or without evidence of a prescription, on one or more occasions;

vi. Interfered with [Name]’s medication management by:

  • On one or more occasion, providing [Name] with medication:
    • that had been prescribed to another individual; and/or
    • that was expired; and/or
    • for which he did not have evidence of a prescription; and/or
    • that was contrary to the advice provided by [Name]’s other health care providers; and/or

vii. On one or more occasion, provided [Name] with advice about her prescription medication and health care that was contrary to the advice provided by her other health care providers;

viii. Made disparaging and inappropriate comments to [Name] a patient or former patient about pharmacy students employed by the Pharmacy.

In particular, it is alleged that he

  • Sexually abused a patient
  • Failed to maintain a standard of profession
  • Abused a patient emotionally, verbally or physically
  • Contravened a federal law with respect to the distribution, purchase, sale or dispensing or prescribing of any drug, and in particular, s. 5(1) of the Controlled Drugs and Substances Act, SC 1996, s 19, and s. 51 of the Benzodiazepines and Other Targeted Substances Regulations, SOR/2000-217
  • Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ghobrial, as pharmacist and/or Designated Manager at Ancaster Village Pharmacy in Ancaster, Ontario, committed professional misconduct in that he

  • Submitted claims to [Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about February 2017-February 2018

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee that was excessive in relation to the service provided
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Girgis Boktor, as pharmacist at Ancaster Village Pharmacy in Ancaster, Ontario, and/or as director of the corporation that owns and operates the Pharmacy, committed professional misconduct in that he

  • Submitted claims to [Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about February 2017-February 2018.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee that was excessive in relation to the service provided
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Groodoyal, while employed as a pharmacy technician at the Transplant Outpatient Pharmacy at Toronto General Hospital in Toronto, Ontario (the “Pharmacy”), committed professional misconduct in that:

  • Between January 2014 and April 2015, she dispensed a drug other than under the supervision or direction of a pharmacist, on one or more occasions.

In particular, it is alleged that she

  • Contravened a term, condition or limitation imposed on her certificate of registration;
  • Failed to maintain the standards of the profession;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, as follows:
    • s. 18 of Ontario Regulation 202/94 under the Pharmacy Act, 1991
  • Engaged in conduct relevant to the practice of pharmacy that, having regard to all of the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable and/or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Guerguis, as a pharmacist and/or Designated Manager at Martindale IDA Pharmacy in St. Catharines, Ontario, committed professional misconduct in that he

  • Submitted claims to [Insurance Claims Adjudicator] that included markups on the unit drug cost that were excessive and unreasonable, in or about March 2017-March 2018

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee that was excessive in relation to the service provided
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hadi committed professional misconduct in that

  • On or about September 24, 2016, he committed sexual assault on a minor;
  • On or about September 24, 2016, he did, without lawful authority, confine a minor;
  • He failed to report to the College that on or about September 26, 2016 he charged with sexual assault and unlawful confinement, under sections 271 and 279(2) of the Criminal Code;
  • On or about March 9, 2017, in written and/or electronic material he submitted to the College during the renewals of his certificate of registration he indicated that he was not the subject of a criminal proceeding, at a time he was charged with sexual assault and unlawful confinement, contrary to sections 271 and 279(2) of the Criminal Code;
  • On or around March 8, 2018, in written and/or electronic material he submitted to the College during the renewals of his certificate of registration he indicated that he was not the subject of a criminal proceeding, at a time he was charged with sexual assault;
  • On or about March 16, 2018, he was found guilty of sexual assault and unlawful confinement, contrary to sections 271 and 279(2) of the Criminal Code;
  • He failed to report to the College that on or about March 16, 2018 he was convicted of sexual assault and unlawful confinement, under sections 271 and 279(2) of the Criminal Code; and
  • He failed to report to the College that on or about October 16, 2018 he was found to have engaged in unprofessional conduct by a hearing tribunal of the Alberta College of Pharmacy.

In particular, it is alleged that he

  • Was found guilty of offences that are relevant to his suitability to practice
  • Contravened a term, condition or limitation imposed on his certificate of registration, as set out in section 5, paragraph 1 (ii) of Ontario Regulation 202/94
  • Breached section 85.6.1 of the Health Professions Procedural Code
  • Breached section 85.6.3 of the Health Professions Procedural Code
  • Signed or issued, in his professional capacity, a document that he knew or ought to have known contained a false or misleading statement
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, as a dispensing pharmacist and/or Designated Manager at Cundles Pharmacy in Barrie Ontario (the Pharmacy), and/or as a director and/or shareholder of the corporation that owned the Pharmacy, committed professional misconduct with respect to:

  • False or unsubstantiated claims submitted to the Ontario Drug Benefit Program (ODB) from the Pharmacy totalling approximately $71,000 for 11 identified drug and other health products, from in or around March of 2015 to in or around February of 2017;
  • Improper claims for prescriptions submitted to the ODB from the Pharmacy totalling approximately $62,000, for the period beginning in or around March of 2015 to in or around February of 2017, in relation to:
    1. Claims for patients who were deceased, for 26 identified prescriptions;
    2. Claims for allergy products for which the required forms were not obtained or retained, for 2 identified prescriptions;
    3. Claims for products in package sizes not listed in the ODB Formulary, for 3 identified prescriptions;
    4. Claims for extemporaneous mixtures where the amount charged exceeded the amount allowed, for 23 identified prescriptions;
    5. Claims for MedsCheck reviews which did not meet the criteria for reimbursement, in relation to 120 identified reviews;
    6. Claims for “no substitution” products for patients for whom the required forms were not obtained, for 372 identified prescriptions;
    7. Claims for Limited Use Products that did not meet the ODB”™s criteria for reimbursement, for 44 identified prescriptions; and/or
    8. Claims for products different from those dispensed, including gabapentin, Ensure Plus and Cymbalta, for identified quantities and amounts.

In particular, it is alleged that he

  • Failed to maintain a standard of the profession
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5, 6 and 15 of the Ontario Drug Benefit Act
  • Permitted, consented to, or approved, either expressly or by implication, the commission of an offence against an Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director
  • Failed to keep records as required respecting his patients
  • Submitted an account or charge for services that he knew was false or misleading
  • Falsified a record relating to his practice
  • Signed or issued, in his professional capacity, a document he knew contained a false or misleading statement
  • Engaged in conduct or preformed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

  • Charged an excessive fee to patient [Name] in relation to her prescription for Nabilone 0.5mg/ml

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hanna, while engaged in the practice of pharmacy as owner, Designated Manager, or dispensing pharmacist at the Cotton Mill Pharmacy in Cornwall, committed professional misconduct in that he

  • Charged an excessive fee in relation to the prescription of patient [Name] for Ziprasidone 15mg;
  • Failed to inform the parents of patient [Name] of less expensive ways in which the same medication could be prepared

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Charged a fee or amount that was excessive in relation to the service or product provided
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Iskandar, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Clinic Pharmacy in Midland, and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that:

    • Between about January 9, 2013 and March 28, 2017, she failed to actively and effectively participate in and/or monitor the day-to-day management of the Pharmacy, including, but not limited to drug procurement and inventory management, record keeping and documentation, billing, and staff and personnel management, and/or she failed to actively and effectively fulfill the duties and responsibilities of a Designated Manager;
    • Between about January 9, 2013 and March 28, 2017, she operated (or permitted, consented to or approved, expressly or impliedly, the operation of) the Pharmacy when it was not managed by a pharmacist who was designated as the Designated Manager of the Pharmacy;
    • Between about June 16, 2016 and March 28, 2017, she failed to ensure that her name, certificate of registration, or both were clearly and publicly displayed in the Pharmacy;
    • On or about January 9, 2013, she signed an Acknowledgment/Change of Designated Manager form containing a false or misleading statement by indicating that “[A.N.]” did not continue to work at the Pharmacy;
    • Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
    • Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
    • Between about December 2014 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
    • Between about December 2014 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
    • Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the provision of routine pharmaceutical care to family members including herself and/or one or more of [family members] by [person] as dispensing pharmacist;
    • Between about June 2015 and December 2016, she permitted, consented to or approved, expressly or impliedly, the selling of certain identified prescription drugs and/or products without valid prescriptions;
    • Between about June 2015 and December 2016, she created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
    • Between about June 2015 and December 2016, she submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to her practice;
  • Signed or issued in her professional capacity a document that she knew contained a false or misleading statement;
  • Submitted an account or charge for services that she knew was false or misleading
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • s. 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
    • s. 146(3) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
    • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
  • Permitted, consented to or approved, either expressly or by implication, the commission of an offence against an Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which she was a director;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Khan, while engaged in the practice of pharmacy as a dispensing pharmacist at Shoppers Drug Mart, located at 300 Taunton Road East in Oshawa (“SDM Taunton”) and/or at Shoppers Drug Mart located at 20 Warren Road in Oshawa (“SDM Warren”), committed professional misconduct in that she

  • Was found guilty of an offence that is relevant to her suitability to practise with respect to findings of guilt made on December 18, 2017, by the Ontario Court of Justice at Oshawa in relation to the following counts:
    • Theft of Oxycocet exceeding $5,000, contrary to section 334(a) of the Criminal Code of Canada;
    • Fraud with respect to Oxycocet exceeding $5,000, contrary to section 380(1)(a) of the Criminal Code of Canada;
    • Theft of Oxycocet not exceeding $5,000, contrary to section 334(b) of the Criminal Code of Canada; and/or
    • Fraud with respect to Oxycocet not exceeding $5,000, contrary to section 380(1)(b) of the Criminal Code of Canada;
  • In the period from in or about February 17, 2017, to April 29, 2017, she misappropriated at least 11,830 tablets of Ratio-Oxycocet and/or Sandoz-Oxycodone Acetaminophen, without authorization or record, from SDM Taunton;
  • In the period from in or about April 5, 2016, to December 10, 2016, she misappropriated at least 78,045 tablets of Ratio-Oxycocet, without authorization or record, from SDM Warren;
  • In the period from in or about February 17, 2017, to April 29, 2017, she submitted approximately 28 false claims, for which there were no valid prescriptions and for which payment was not required, to the Ontario Drug Benefit program (“ODB”) from SDM Taunton; and/or
  • In the period from in or about April 5, 2016, to December 10, 2016, she submitted approximately 304 false claims, for which there were no valid prescriptions and for which payment was not required, to the ODB from SDM Warren.

In particular, it is alleged that she

  • Was found guilty of an offence that is relevant to her suitability to practice;
  • Failed to maintain a standard of practice of the profession;
  • Dispensed or sold drugs for an improper purpose;
  • Failed to keep records as required respecting her patients;
  • Falsified a record relating to her practice;
  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement;
  • Submitted an account or charge for services that she knew was false or misleading
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • Section 155 of the Drug and Pharmacies Regulation Act
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • Sections C.01.041, G.03.002, and/or G.03.012 of the Food and Drug; Regulations, C.R.C., c. 870, as amended, to the Food and Drugs Act, R.S,C. 1985, c. F-27, as amended;
    • Section 4 of the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
    • Section 31 of the Narcotic Control Regulations, C.R.C., c. 1041, as amended, to the Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended;
    • Section 8 of the Narcotics Safety and Awareness Act, 2010, S.O. 2010, c.22, as amended, and the Notice issued thereunder, and/or section 11 of the Narcotic Safety and Awareness Act, 2010, S.O. 2010 C.22, as amended;
    • Section 15 of the Ontario Drug Benefit Act, R.S.O. 1990, C.0.10, as amended;
    • Sections 334(a), 334(b), 380(1)(a), and/or 380(1)(b) of the Criminal Code of Canada;
  • Knowingly permitted the premises in which a pharmacy was located to be used for unlawful purposes;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Kula, as Director of Pharmaceutical Services at Meds Via Canada (“MVC”), and/or as director of the corporate owner of MVC, in or about 2012-2017, and/or as pharmacist and Designated Manager at The Medicine Shoppe, in Toronto, Ontario (the “Pharmacy”), and/or as director of the corporate owner of the Pharmacy, in or about 2012-2013, committed professional misconduct in that he

  • Sold drugs by retail to patients in the U.S. at premises other than an accredited pharmacy;
  • Sold by retail and/or dispensed prescription drugs to patients in the U.S. without a lawful and/or otherwise valid prescription; and/or
  • Contravened the OCP policies on Operating Internet Sites, dated June 2001; Internet Pharmacies, dated May 2012; and/or Prescriptions – Out of Country, dated January-February 2003.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, sections 139, 146, 147, 149, 155 and/or 158 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended;
  • Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections C.01.041 and/or C.01.042 of the Food and Drug Regulations, C.R.C., c. 870, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Ma, while engaged in the practice of pharmacy as director, shareholder, owner, Designated Manager, and/or dispensing pharmacist at Pharm Can Drug Mart (the “Pharmacy”) in Ottawa, committed professional misconduct in that he:

  • Dispensed monitored drugs without acting on Narcotic Monitoring System alerts for one or more of certain identified prescriptions;
  • Dispensed monitored drugs without documenting the actions taken, and/or the reason(s) for not taking any action, in response to Narcotic Monitoring System alerts for one or more of certain identified prescriptions; and/or,
  • Dispensed one or more of certain identified prescriptions without labelling the container in which the drug(s) was dispensed.

In particular, it is alleged that he:

  • Failed to maintain a standard of practice of the profession;
  • Failed to keep records as required respecting his patients and/or practice;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular:
    • Sections 156 and 166 of the Drug and Pharmacies Regulation Act, section 20(1) of Ontario Regulation 264/16, and/or
    • Section 54 of Ontario Regulation 58/11;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. McAnulty committed professional misconduct in that he

  • Was employed in or worked in Tom’s Pharmacy while his licence was suspended for cause;
  • Used the title “pharmacist” while his certificate of registration was suspended, including but not limited to: on his LinkedIn profile; when quoted in an article in the Toronto Star on or about December 22, 2017; when calling in to a radio show on or about September 4, 2018; and/or in interactions with patients and the public at Tom’s Pharmacy;
  • Dispensed or sold drugs at Tom’s Pharmacy when he was not a pharmacist, in particular but not limited to on or about October 20, 2017, February 22, 2018, and/or September 15, 2018;
  • Engaged in the controlled acts of prescribing, dispensing, selling or compounding a drug as defined in the Drug and Pharmacies Regulation Act, or supervising the part of the pharmacy where such drugs are kept at Tom’s Pharmacy, when he was not a member authorized by a health profession Act to perform the controlled act, in particular but not limited to on or about October 20, 2017, February 22, 2018, and/or September 15, 2018;
  • Provided information or education to patients at Tom’s Pharmacy, in particular but not limited to [Patient A] on or about February 20, 2018, [Patient B] in or after August 2018, and other customers on or about September 15, 2018;
  • Provided instructions regarding the dispensing of extra tablets of sildenafil to [Patient C] in or around August 2018 to October 2018;
  • Removed prescription drugs from Tom’s Pharmacy without a prescription, including but not limited to Lynparza and Premarin;
  • Sold drugs without a prescription, including but not limited to Lynparza and Premarin
  • Engaged in certain conduct at [Pharmacy 1] and/or [Pharmacy 2] on or about March 7, 2018; and/or
  • Demonstrated a pattern of ungovernability

In particular, it is alleged that he

  • Inappropriately used a term, title or designation in respect of his practice
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, in particular but not limited to:
    • subsection 10(1) of the Pharmacy Act
    • section 10(2) of the Pharmacy Act
    • section 143 of the Drug and Pharmacies Regulation Act
    • section 149 of the Drug and Pharmacies Regulation Act
    • section 155 of the Drug and Pharmacies Regulation Act
    • section 27 of the Regulated Health Professions Act, 1991
  • Contravened any federal, provincial or territorial law or municipal by-law, with respect to the distribution, purchase, sale, or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis, whose purpose is to protect or promote public health, or that is otherwise relevant to his suitability to practice, in particular but not limited to subsection C.01.041 of the Food and Drug Regulations, C.R.C., c. 870
  • Failed to comply with an order of a Committee or a panel of a Committee of the College, namely the interim suspension order of the Inquiries, Complaints and Reports Committee, effective as of June 30, 2017
  • Practised the profession while his certificate of registration was under suspension
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional
  • Engaged in conduct that is unbecoming a member

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. McAnulty committed professional misconduct in that he:

  • Failed to successfully complete, at his own expense, the ProBE Program on Professional/Problem Based Ethics for healthcare professionals, with an unconditional pass, within twelve (12) months of the date of the Order made by a panel of the Discipline Committee on or about March 29, 2018;
  • Held himself out as a person who is qualified to practise in Ontario as a pharmacist while his certificate of registration was suspended, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019;
  • Was employed in or worked in Tom’s Pharmacy while his licence was suspended for cause, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019;
  • Engaged in the practice of pharmacy at Tom’s Pharmacy while his certificate of registration was suspended, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019;
  • Interacted with patients or customers at Tom’s Pharmacy while his certificate of registration was suspended, in particular but not limited to on or about April 3 to 15, 2019 and/or on or about May 28 to 29, 2019; and/or
  • Demonstrated a pattern of ungovernability.

In particular, it is alleged that he:

  • Contravened a term, condition or limitation imposed on his certificate of registration;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, in particular but not limited to:
    • section 10(2) of the Pharmacy Act; and/or
    • section 143 of the Drug and Pharmacies Regulation Act;
  • Failed to comply with an order of a Committee or a panel of a Committee of the College;
  • Practised the profession while his certificate of registration was under suspension;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and/or Designated Manager at Pars Medical Pharmacy in Richmond Hill, committed professional misconduct in that he

  • Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to himself, and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 1], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or falsified records of such authorization, in relation to certain identified prescriptions;
  • Dispensed medications and/or supplies to [Patient 2], and/or submitted claims to [Insurer] for such medications or supplies, without the required authorization from a prescriber, and/or failed to document such authorization, in relation to certain identified prescriptions;
  • Obtained new prescriptions and/or prescription refills for himself for certain identified prescriptions;
  • Dispensed prescription medications to himself in relation to certain identified prescriptions; and/or
  • Submitted claims to [Insurer] for 200 diabetic test strips for himself on or about October 27, 2014, as though the prescription had been authorized by him in accordance with the regulations under the Pharmacy Act, 1991 which was not accurate, and/or then falsified a record retroactively to indicate that the claim had been authorized by a physician before being submitted.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Practised the profession while he was in a conflict of interest
  • Failed to keep records as required respecting his patients
  • Falsified a record relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Mosallam, as pharmacist and Designated Manager at Pars Medical Pharmacy in Richmond Hill, Ontario, and as shareholder of Ultra Care Pharmacy Inc., the owner and operator of the Pharmacy, committed professional misconduct in that he

  • Submitted false or unsubstantiated claims to the Ontario Drug Benefit Program totalling approximately $80,000.00 in relation to nine identified drug and/or other health products in or about January 2013-March 2015; and/or
  • Created false records of billing and/or dispensing transactions in relation to the false or unsubstantiated claims submitted to the Ontario Drug Benefit Program in relation to nine identified drug and/or other health products in or about January 2013-March 2015

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified a record relating to his practice
  • Signed or issued, in his professional capacity, a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened, while engaged in the practice of pharmacy, a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, the Ontario Drug Benefit Act, R.S.O. 1990 c.O. 10, sections 5, 6 and/or 15, as amended, and/or Ontario Regulation 201/96, section 27
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Mourid, while engaged in the practice of pharmacy as director, shareholder, Designated Manager and/or dispensing pharmacist at St. Mary Pharmacy, Ontario (“the Pharmacy”) committed professional misconduct in that she

  • Submitted and/or permitted, consented to or approved, either expressly or by implication, the submission of, accounts or charges for services that she knew were false or misleading to the Ontario Drug Benefit program through the Pharmacy for:
      1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;
  • Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of pharmacy records relating to her practice in relation to the dispensing of and/or claims made to the Ontario Drug Benefit program through the Pharmacy for:
      1. one or more of certain identified drugs and/or products from on or about September 1, 2014 on or about August 31, 2016,
      2. one or more of certain identified MedsCheck reviews submitted from on or about August 23, 2012 to on or about August 23, 2016, which were non-compliant with the guidelines of the Ministry of Health and Long Term Care;
      3. one or more of certain identified chronic use medications submitted on or after October 1, 2015, with respect to which there was missing and/or incomplete frequent dispensing documentation;
      4. one or more influenza vaccines administered to ineligible patients under the age of 18 and /or with respect to which there was missing documentation, including RX# 117551, 152333, 153737 and/or 154095;
      5. one or more of certain identified “Limited Use” products, which did not meet the clinical criteria for reimbursement specified in the Ontario Drug Benefit Formulary;
      6. one or more prescriptions for deceased patients, includingRX# 137062, 159995, 160004, 160030, 160031, 160102, 160103, 160104, 160105 and/or 160106;
      7. one or more invalid extemporaneous preparations, including RX# 123305, 124635, 133807, 152568, 156687 and/or 173912;
      8. one or more of certain identified transactions, in which the patient”™s Ontario Drug Benefit eligibility card was not obtained or retained by the Pharmacy, and/or
      9. one or more nutritional products, including RX# 113182, 119926, 122722, 126487, 133094, 137417, 144737, 147421, 156605, 159973, 164544, 169389, 172746, 175796 and/or 184969 for a patient who did not meet the eligibility criteria specified in the Ontario Drug Benefit Formulary;
  • Failed to ensure that the Pharmacy complied with all legal requirements, including but not limited to, requirements regarding record keeping, documentation, and billing the Ontario Drug Benefit Plan.
  • Failed to keep records of monthly Ontario Drug Benefit eligibility cards or a copy of the cards with respect to each person for whom a drug was dispensed, as required by section 29 of Ontario Regulation 201/96, under the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, from on or about October, 2014 to on or about June, 2016
  • Submitted to the Ontario College of Pharmacists and/or the Ministry of Health and Long Term Care invoices, receipts and/or other documentation that she knew, or ought to have known, was false, misleading or unreliable to substantiate the purchase and/or transfer of one or more of certain identified drugs and/or products

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting her patients
  • Falsified and/or permitted, consented to or approved, either expressly or by implication, the falsification of records relating to her practice
  • Signed or issued, in her professional capacity, and/or permitted, consented to or approved, either expressly or by implication, the signing or issuing of a document that she knew contained a false or misleading statement
  • Submitted and/or permitted, consented to or approved the submission of accounts or charges for services that she knew to be false or misleading
  • Contravened the Pharmacy Act,1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts and in particular:
    1. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
    2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Permitted, consented to or approved, either expressly or by implication, the contravention of a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    1. Sections 5, 6, 15(1)(b)and/or 17(2) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or Ontario Regulation 201/96 made thereunder
    2. Sections 155 and 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H-4, as amended
  • Engaged in conduct or performed an act or acts relevant to the practice of pharmacy that, having regarding to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Musitano, as dispensing pharmacist and/or Designated Manager at Concession Medical Pharmacy in Hamilton, Ontario, committed professional misconduct, in or about 2016-2019, in that she:

  • Sold and/or dispensed certain identified prescription drugs to the patient, [Patient], without lawful or otherwise valid prescriptions;
  • Failed to keep records as required regarding certain identified prescription drugs dispensed to the patient, [Patient];
  • Falsified records regarding certain identified prescription drugs dispensed to the patient, [Patient]; and/or
  • Contravened the OCP policy on Prescriptions – Out of Country, dated January-February 2003, with respect to entering into an agreement or otherwise facilitating the practice of Dr. [Name] to re-issue prescriptions for the patient, [Patient], despite not having any substantive professional relationship with the patient, in relation to certain identified transactions.

 

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Failed to provide an appropriate level of supervision to a person whom she was professionally obligated to supervise, including other pharmacist and non-pharmacist staff at the Pharmacy
  • Failed to keep records as required
    • respecting her patients (for conduct up to and including May 4, 2017); and/or
    • respecting her patients or practice (for conduct on or after May 5, 2017)
  • Falsified a record
    • relating to her practice (for conduct up to and including May 4, 2017), and/or
    • relating to her practice or a person’s health record (for conduct on or after May 5, 2017)
  • Signed or issued, in her professional capacity, a document
    • that she knew contained a false or misleading statement (for conduct up to and including May 4, 2017), and/or
    • that she knew or ought to have known contained a false or misleading statement (for conduct on or after May 5, 2017)
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular,
    • sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended,
    • sections 54, 55, 56 and/or 57 of Ontario Regulation 58/11, as amended, and/or
    • sections 20 and/or 21 of Ontario Regulation 264/16, as amended (for conduct up to an including May 4, 2017), and/or
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
    • sections 155 and/or 156 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended, and/or
    • sections 20 and/or 21 of Ontario Regulation 264/16, as amended (for conduct on or after May 5, 2017)
  • Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular,
    • sections C.01.041, C.01.042 and/or C.01.042.1 of the Food and Drug Regulations, C.R.C., c 870, as amended (for conduct up to and including May 4, 2017), and/or
  • Contravened any federal, provincial or territorial law or municipal by-law,
  1. with respect to the distribution, purchase, sale or dispensing or prescribing of any drug or product, the administering of any substance, or the piercing of the dermis,
  2. whose purpose is to protect or promote public health, or
  3. that is other relevant to the member’s suitability to practise,

and in particular,

    • sections C.01.041, C.01.042 and/or C.01.042.1 of the Food and Drug Regulations, C.R.C., c 870, as amended (for conduct on or after May 5, 2017)
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner at the MT Cross Pharmacy, Greenhill Pharmacy, and/or I-Care Drug Mart, all in Hamilton, Ontario, committed professional misconduct in that he

  • Submitted (or permitted the submission of) unsubstantiated billings to third party payors, in respect of certain identified products.
  • Failed to keep records as required respecting his patients or practice with respect to certain identified prescriptions.
  • Operated or permitted the MT Cross Pharmacy to operate on or about March 28, 2018, without the supervision of a pharmacist who is physically present.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting his patients or practice
  • Falsified a record in relation to his practice
  • Signed or issued, in his professional capacity, a document he knew or ought to have known contained a false or misleading statement
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading
  • Contravened s. 146(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasim, while engaged in the practice of pharmacy as dispensing pharmacist, designated manager and/or owner at the MT Cross Pharmacy in Hamilton, Ontario, in the period from about June 27, 2017, to May 16, 2018, committed professional misconduct in that he

  • Failed to take all reasonable steps to keep the Pharmacy”™s narcotic and controlled drugs inventory secure against loss and theft;
  • Failed to conduct physical counts and reconciliations of narcotic and controlled drugs inventory as required by the College policy entitled “Medication Procurement and Inventory Management”;
  • Failed to keep adequate records in relation to the Pharmacy”™s inventory of narcotics and controlled drugs;
  • Failed to ensure that delivery slips for deliveries of narcotics and controlled drugs were signed by the patients to whom they were delivered.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required respecting his practice
  • Contravened s. 152(1) of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4
  • Contravened a federal or provincial law with respect to the distribution, purchase, sale, or dispensing or prescribing of drugs, in particular ss. 30 and 43 of the Narcotic Control Regulations, C.R.C., c. 1041.
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Nasr, while engaged in the practice of pharmacy at Clinic Pharmacy in Midland, committed professional misconduct in that:

  • Between about January 9, 2013 and March 28, 2017, he failed to provide and/or update the Ontario College of Pharmacists with the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
  • Between about January 9, 2013 and March 28, 2017, he submitted annual renewal certificates and/or information to the College that were/was inaccurate with respect to the name, address, telephone number and facsimile number of each person or business for or through which he engaged in the practice of pharmacy;
  • Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for brand name medication when generic medication was dispensed, with respect to certain identified medication;
  • Between about December 2014 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about December 2014 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about June 2015 and December 2016, he provided and/or purported to provide routine pharmaceutical care to family members including [family members], and/or including himself as patient;
  • Between about June 2015 and December 2016, he signed certain identified prescription hardcopies as dispensing pharmacist, for ostensible prescriptions for family members including [family members], and/or including himself as patient, but that were not valid prescriptions;
  • Between about June 2015 and December 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the selling of certain identified prescription drugs and/or products and/or the processing of prescriptions when those prescriptions were not valid;
  • Between about June 2015 and December 2016, he sold (or permitted, consented to or approved, expressly or impliedly, the sale of) certain identified prescription drugs and/or products without valid prescriptions;
  • Between about June 2015 and December 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified prescription drugs and/or products without valid prescriptions.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession;
  • Falsified a record relating to his practice;
  • Signed or issued in his professional capacity a document that he knew contained a false or misleading statement;
  • Submitted an account or charge for services that he knew was false or misleading;
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • s. 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4;
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. 15(1)(b) of the Ontario Drug Benefit Act, R.S.O. 1990, c. O.10;
    • s. C.01.041 of the Food and Drug Regulations, C.R.C. 870, made under the Food and Drugs Act, R.S.C. 1985, c. F-27;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Paterson, while engaged in the practice of pharmacy at the Shoppers Drug Mart at 125 The Queensway in Etobicoke, Ontario, committed professional misconduct in that she

  • Failed to exercise reasonable professional diligence when she dispensed the wrong medication, namely hydromorphone, to patient [Patient], whose prescription called for hydrocodone

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, or the regulations under those Acts, and in particular, section 155 of the Drug and Pharmacies Regulation Act, R.S.O. 1990, c. H.4, as amended
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, section C.01.041 of the Food and Drug Regulations, C.R.C., c. 870, as amended
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

It is further alleged that Ms. Paterson”™s professional care of a patient displayed a lack of knowledge, skill or judgment of a nature or to an extent that demonstrates that she is unfit to continue to practise or that her practice should be restricted.

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Peters, while employed as a pharmacy technician at Muxlow Pharmacy in Meaford, Ontario committed professional misconduct in that

  • On or about December 1, 2016, he stole fentanyl patches from the Pharmacy
  • On February 8, 2018 findings of guilt were made against him by the Ontario Court of Justice at Owen Sound, Ontario in relation to the following counts:
    • Theft under $5000 (fentanyl), contrary to s. 334(b) of the Criminal Code;
    • Possession of cocaine, contrary to s. 4(1) of the Controlled Drugs and Substances Act;
    • Possession of hydromorphone, contrary to s. 4(1) of the Controlled Drugs and Substances Act.

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Dispensed drugs for an improper purpose
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional
  • Was found guilty of offences that are relevant to his suitability to practise

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Popoola committed professional misconduct in that she:

  • Failed to maintain personal professional liability insurance from approximately January 2016 to approximately March 24, 2019 while maintaining her registration in Part A of the Register;
  • Made false statements respecting her personal professional liability insurance when she renewed her registration in Part A of the Register on or about March 7, 2016, March 9, 2017, and March 9, 2018; and
  • Made false statements respecting her provision of at least 600 hours of patient care over the preceding three years while practising the profession of pharmacy when she renewed her registration in Part A of the Register on or about March 9, 2018 and April 8, 2019.

In particular, it is alleged that she:

  • Failed to maintain a standard of practice of the profession;
  • Signed or issued, in her professional capacity, documents that she knew and/or ought to have known contained false or misleading statements;
  • Engaged in conduct or performed acts that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Saleh committed professional misconduct in that

  • On or about September 14, 2017, he committed Sexual Assault, contrary to section 271 of the Criminal Code of Canada, for which he was found criminally guilty on March 6, 2019.

In particular, it is alleged that he

  • Has been found guilty of an offence that is relevant to his suitability to practice;
  • Engaged in conduct that is unbecoming a member.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Hani Salib, while engaged in the practice of pharmacy as Designated Manager and/or dispensing pharmacist at Queentario Pharmacy in Mississauga, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that

  • Between about June 1, 2014 and November 1, 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of certain identified drugs and/or products that were not dispensed;
  • Between about June 1, 2014 and November 1, 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for certain identified drugs and/or products that were not dispensed;
  • Between about June 1, 2014 and November 1, 2016, he introduced into active inventory (or permitted, consented to or approved, expressly or impliedly, the introduction into active inventory of) certain identified drugs and/or products that were acquired from unauthorized and/or improper sources;
  • Between about July 28, 2015 and November 4, 2016, he failed to discover and/or report a loss or theft of narcotics with respect to Oxycodone CR 40mg;
  • Between about July 28, 2015 and November 4, 2016, he failed to perform and/or maintain accurate inventory counts and/or reconciliations of narcotics; and/or
  • He dispensed a prescription for Oxycodone CR 80mg in doses and/or quantities that were clinically questionable, without taking and/or documenting appropriate and/or sufficient steps to assess the propriety of the prescription, on or about the following dates:
    • January 10, 2014
    • April 15, 2014
    • July 14, 2014
    • October 15, 2014
    • January 5, 2015
    • April 16, 2015
    • July 10, 2015

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Falsified a record relating to his practice
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • s. 42 of the Narcotic Control Regulations, CRC c 1041, made under the Controlled Drugs and Substances Act, SC 1996, c 19
  • Returned to stock or again sold or dispensed a drug previously sold or dispensed and delivered
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and
Reports Committee, it is alleged that Mr. Salomon committed professional
misconduct in that he contravened
terms, conditions or limitations imposed on his certificate of registration by
a September 5, 2017 order of a panel of the Discipline Committee of the Ontario
College of Pharmacists, and, in particular he failed to:

  • meet at least five (5) times with a practice mentor, at a place to be determined by the practice mentor, for the purpose of reviewing his ethical and professional obligations in relation to consent, compliance with program claim requirements, maintaining accurate records, and any other issues raised by the facts and findings of professional misconduct in his September 5, 2017 disciplinary hearing, and identifying areas in his practice with respect to these issues that require remediation within 12 months of the September 5, 2017 Discipline Committee Order.

 

  • provide the practice mentor with the following documents related to his September 5, 2017 discipline proceeding:
    • the Notice of Hearing;
    • the Agreed Statement of Facts;
    • the Joint Submission on Order; and
    • the Panel’s Decision and Reasons, if and when available.
  • develop with the practice mentor a learning plan to address the areas of the his practice requiring remediation.
  • demonstrate to the practice mentor, in a manner directed by and acceptable to the practice mentor, that the he has achieved success in meeting the goals established in the learning plan.
  • ensure that the practice mentor reports the result of the mentorship program to the Manager, Investigations and Resolutions at the College, after its completion, no later than twelve (12) months from the date of the September 5, 2017 Discipline Committee Order.

In particular, it is alleged that he

  • Contravened terms, conditions or limitations imposed on his certificate of registration
  • Failed to comply with a September 5, 2017 order of a panel of the Discipline Committee of the Ontario College of Pharmacists
  • Engaged in conduct or performed an act relevant
    to the practice of pharmacy that, having regard to all the circumstances would
    reasonably be regarded by members as disgraceful, dishonourable or
    unprofessional

 

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Ms. Sharma, as staff pharmacist at Torbram Pharmacy (“Pharmacy”) in Brampton, Ontario, and/or as director and shareholder of the corporate owner of the Pharmacy, committed professional misconduct with respect to certain identified false or unsubstantiated claims submitted by the Pharmacy to the Ontario Drug Benefit Program totaling approximately $190,000, in or about July 2015-June 2017.

In particular, it is alleged that she

  • Failed to maintain a standard of practice of the profession

  • Falsified a record relating to her practice (for conduct up to and including May 4, 2017), and/or
  • Falsified a record relating to her practice or a person”™s health record (for conduct on or after May 5, 2017)

  • Signed or issued, in her professional capacity, a document that she knew contained a false or misleading statement (for conduct up to and including May 4, 2017), and/or
  • Signed or issued, in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement (for conduct on or after May 5, 2017)

  • Submitted an account or charge for services that she knew was false or misleading (for conduct up to and including May 4, 2017) and/or
  • Submitted an account or charge for services or products that she knew or ought to have known was false or misleading (for conduct on or after May 5, 2017)

  • Charged a fee that was excessive in relation to the service provided (for conduct up to and including May 4, 2017), and/or
  • Charged a fee or amount that was excessive in relation to the service or product provided (for conduct on or after May 5, 2017)

  • Contravened, while engaged in the practice of pharmacy, any federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular, sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or section 27 of O.Reg. 201/96, as amended (for conduct up to and including May 4, 2017), and/or
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability Act and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular, sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or section 27 of O.Reg. 201/96, as amended (for conduct on or after May 5, 2017)

  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Syed, as dispensing pharmacist and/or Designated Manager at MobilRx in Lynden, Ontario (“the Pharmacy”), and/or as director and shareholder of the corporation that owns the Pharmacy, committed professional misconduct, in or about January-February 2018, in that he:

  • Dispensed less than the full quantity of the drug prescribed for the patient, [Patient 1], without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so, as required;
  • Charged excessive dispensing fees for dispensing the drug prescribed for the patient, [Patient 1], on a daily basis rather than the full quantity prescribed, without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so; and/or
  • Entered into an arrangement with [Person A], the manager of [Facility], requiring residents, including the patient, [Patient 1], to accept prescription services from the Pharmacy and/or for all prescriptions to be filled on a daily basis.

In particular, it is alleged that he:

  • Failed to maintain the standard of practice of the profession;
  • Failed to provide an appropriate level of supervision to a person whom he was professionally obligated to supervise;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Entered into an agreement that restricted a person’s choice of a pharmacist without the consent of the person;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
    • sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or
    • sections 18 and/or 27 of Ontario Regulation 201/96, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming a member.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Syed, as dispensing pharmacist and/or Designated Manager at MobilRx in Lynden, Ontario (“the Pharmacy”), and/or as director and shareholder of the corporation that owns the Pharmacy, committed professional misconduct, in or about February-May 2018, in that he

  • Dispensed less than the full quantities of drugs prescribed for the patient, [Patient], without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so, as required;
  • Charged excessive dispensing fees for dispensing the drugs prescribed for the patient, [Patient], on a daily basis rather than the full quantities prescribed, without the consent of the patient or other authorization, notification to the prescriber and/or documentation of any valid reason for doing so; and/or
  • Entered into an arrangement with [Person A], the manager of [Facility], requiring residents, including the patient, [Patient], to accept prescription services from the Pharmacy and/or for all prescriptions to be filled on a daily basis.

 

In particular, it is alleged that he

  • Failed to maintain the standard of practice of the profession;
  • Failed to provide an appropriate level of supervision to a person whom he was professionally obligated to supervise;
  • Submitted an account or charge for services or products that he knew or ought to have known was false or misleading;
  • Charged a fee or amount that was excessive in relation to the service or product provided;
  • Entered into an agreement that restricted a person’s choice of a pharmacist without the consent of the person;
  • Contravened the Act, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario Drug Benefit Act or the regulations under those Acts, and in particular,
    • sections 5 and/or 6 of the Ontario Drug Benefit Act, R.S.O. 1990, c.O.10, as amended, and/or
    • sections 18 and/or 27 of Ontario Regulation 201/96, as amended;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct that is unbecoming a member.

 

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Xu, while engaged in the practice of pharmacy as a Designated Manager and/or dispensing pharmacist at Warden Pharmacy in Markham, Ontario (the “Pharmacy”), and/or as a director and/or shareholder of the corporation that owned and/or operated the Pharmacy, committed professional misconduct in that

  • Between about January 1, 2015 and November 30, 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) charges for drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about January 1, 2015 and November 30, 2016, he created (or permitted, consented to or approved, expressly or impliedly, the creation of) false and/or misleading pharmacy records documenting the dispensing of drugs and/or products that were not dispensed, with respect to certain identified drugs and/or products;
  • Between about January 1, 2015 and November 30, 2016, he failed to take reasonable steps to ensure that he and/or the Pharmacy complied with all legal requirements, including (without limitation) legal requirements relating to record keeping, documentation, and billing the Ontario Drug Benefit Program, with respect to certain identified transactions;
  • Between about January 1, 2015 and November 30, 2016, he sold by retail (or permitted, consented to or approved, expressly or impliedly, the sale by retail of) prescription drugs and/or products without valid prescriptions, with respect to certain identified transactions;
  • Between about January 1, 2015 and November 30, 2016, he failed to maintain the records required to be maintained by s. 29 of O. Reg. 201/96, made under the Ontario Drug Benefit Act, RSO 1990, c O.10, with respect to certain identified transactions;
  • Between about January 1, 2015 and November 30, 2016, he submitted (or permitted, consented to or approved, expressly or impliedly, the submission of) erroneous, invalid, and/or otherwise improper charges to the Ontario Drug Benefit Program for MedsChecks, with respect to certain identified charges

In particular, it is alleged that he

  • Failed to maintain a standard of practice of the profession
  • Failed to keep records as required
  • Falsified a record relating to his practice
  • Signed or issued in his professional capacity a document that he knew contained a false or misleading statement
  • Submitted an account or charge for services that he knew was false or misleading
  • Contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act, the Regulated Health Professions Act, 1991 or the regulations under those Acts, and in particular:
    • s. 155 of the Drug and Pharmacies Regulation Act
  • Contravened a federal or provincial law or municipal by-law with respect to the distribution, sale or dispensing of any drug or mixture of drugs, and in particular:
    • ss. 5, 6, and/or 15(1)(b) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended, and/or
    • s. 29 of Ontario Regulation 201/96 made thereunder
    • s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act, RSC 1985, c F-27
  • Permitted, consented to or approved, either expressly or by implication, the commission of an offence against an Act relating to the practice of pharmacy or to the sale of drugs by a corporation of which he was a director, and in particular:
    • ss. 5, 6, and/or 15(1)(b) of the Ontario Drug Benefits Act, R.S.O. 1990, c. O.10, as amended
    • s. 29 of Ontario Regulation 201/96 made thereunder
    • s. C.01.041 of the Food and Drug Regulations, CRC, c 870, made under the Food and Drugs Act, RSC 1985, c F-27, and/or
    • s. 155 of the Drug and Pharmacies Regulation Act
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional

Hearing Dates: TBA

Summary of Allegations

As a result of a referral by the Inquiries, Complaints and Reports Committee, it is alleged that Mr. Zandi, while engaged in the practice of pharmacy in Toronto, Ontario, on or about October 20, 2018, committed professional misconduct in that he

  • Engaged in sexual touching of [Name] without her consent

In particular, it is alleged that he

  • Contravened a federal law that is relevant to his suitability to practise: namely, s. 271 of the Criminal Code;
  • Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members of the profession as disgraceful, dishonourable or unprofessional;
  • Engaged in conduct unbecoming a pharmacist.